MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.850
+0.071 (9.14%)
Jan 14, 2025, 4:00 PM EST - Market closed
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $33.62 million as of January 15, 2025. Its market cap has decreased by -11.47% in one year.
Market Cap
33.62M
Enterprise Value
31.90M
1-Year Change
-11.47%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $33.62M, a decrease of -91.30%. That is a compound annual growth rate of -52.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2025 | 33.62M | 21.97% |
| Dec 31, 2024 | 27.56M | -25.38% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.26B |
| UnitedHealth Group | 479.18B |
| Novo Nordisk | 385.14B |
| Johnson & Johnson | 342.03B |
| AbbVie | 309.55B |
| Merck & Co. | 251.07B |
| AstraZeneca | 207.72B |
| Thermo Fisher Scientific | 207.43B |